These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37789566)

  • 41. Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018.
    Punjani R; Larson TC; Wagner L; Davis B; Horton DK; Kaye W
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):203-211. PubMed ID: 36200180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for amyotrophic lateral sclerosis: A regional United States case-control study.
    Andrew AS; Bradley WG; Peipert D; Butt T; Amoako K; Pioro EP; Tandan R; Novak J; Quick A; Pugar KD; Sawlani K; Katirji B; Hayes TA; Cazzolli P; Gui J; Mehta P; Horton DK; Stommel EW
    Muscle Nerve; 2021 Jan; 63(1):52-59. PubMed ID: 33006184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics.
    Schmidt S; Allen KD; Loiacono VT; Norman B; Stanwyck CL; Nord KM; Williams CD; Kasarskis EJ; Kamel F; McGuire V; Nelson LM; Oddone EZ
    Neuroepidemiology; 2008; 30(3):191-204. PubMed ID: 18421219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and epidemiological characteristics of amyotrophic lateral sclerosis in an Egyptian cohort.
    Soliman R; Onbool E; Omran K; Fahmy N
    Neurol Sci; 2024 Sep; ():. PubMed ID: 39349916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions.
    Mehta P; Horton DK; Kasarskis EJ; Tessaro E; Eisenberg MS; Laird S; Iskander J
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(50):1379-1382. PubMed ID: 29267263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.
    Peter RS; Rosenbohm A; Dupuis L; Brehme T; Kassubek J; Rothenbacher D; Nagel G; Ludolph AC
    Eur J Epidemiol; 2017 Oct; 32(10):901-908. PubMed ID: 28975435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparing for a U.S. National ALS Registry: Lessons from a pilot project in the State of Georgia.
    Benatar M; Wuu J; Usher S; Ward K
    Amyotroph Lateral Scler; 2011 Mar; 12(2):130-5. PubMed ID: 20843169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China.
    Zou ZY; Cui LY; Sun Q; Li XG; Liu MS; Xu Y; Zhou Y; Yang XZ
    Neurobiol Aging; 2013 Apr; 34(4):1312.e1-8. PubMed ID: 23046859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS.
    Chen L
    Rev Neurol (Paris); 2021 Apr; 177(4):333-340. PubMed ID: 33036763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age at onset of amyotrophic lateral sclerosis in China.
    Liu MS; Cui LY; Fan DS;
    Acta Neurol Scand; 2014 Mar; 129(3):163-7. PubMed ID: 23819875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology and diagnostic process of amyotrophic lateral sclerosis as distinct from myelopathy: 5-year cohort study of whole-population in South Korea.
    Kim JM; Park JH; Kim HS; Lee JW; Lim HS; Choi WA; Kang SW
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):547-554. PubMed ID: 30421999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "ALS reversals": demographics, disease characteristics, treatments, and co-morbidities.
    Harrison D; Mehta P; van Es MA; Stommel E; Drory VE; Nefussy B; van den Berg LH; Crayle J; Bedlack R;
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):495-499. PubMed ID: 29607695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Department of Veterans Affairs Biorepository Brain Bank: a national resource for amyotrophic lateral sclerosis research.
    Brady CB; Trevor KT; Stein TD; Deykin EY; Perkins SD; Averill JG; Guilderson L; McKee AC; Renner SW; Kowall NW
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):591-7. PubMed ID: 23971854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of amyotrophic lateral sclerosis in the United States, 2018.
    Mehta P; Raymond J; Zhang Y; Punjani R; Han M; Larson T; Muravov O; Lyles RH; Horton DK
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; ():1-7. PubMed ID: 37602649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.
    Ahmeti KB; Ajroud-Driss S; Al-Chalabi A; Andersen PM; Armstrong J; Birve A; Blauw HM; Brown RH; Bruijn L; Chen W; Chio A; Comeau MC; Cronin S; Diekstra FP; Soraya Gkazi A; Glass JD; Grab JD; Groen EJ; Haines JL; Hardiman O; Heller S; Huang J; Hung WY; ; Jaworski JM; Jones A; Khan H; Landers JE; Langefeld CD; Leigh PN; Marion MC; McLaughlin RL; Meininger V; Melki J; Miller JW; Mora G; Pericak-Vance MA; Rampersaud E; Robberecht W; Russell LP; Salachas F; Saris CG; Shatunov A; Shaw CE; Siddique N; Siddique T; Smith BN; Sufit R; Topp S; Traynor BJ; Vance C; van Damme P; van den Berg LH; van Es MA; van Vught PW; Veldink JH; Yang Y; Zheng JG;
    Neurobiol Aging; 2013 Jan; 34(1):357.e7-19. PubMed ID: 22959728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of amyotrophic lateral sclerosis in Lebanon-a chart review.
    Malek E; Ismail H; Doumiati H; Salameh J
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Nov; 21(7-8):614-619. PubMed ID: 32633637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model.
    Horton DK; Mehta P; Antao VC
    JAMA; 2014 Sep; 312(11):1097-8. PubMed ID: 25057819
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical and prognostic features of ALS/MND in different phenotypes-data from a hospital-based registry.
    Wei QQ; Chen Y; Chen X; Cao B; Ou R; Zhang L; Hou Y; Shang H
    Brain Res Bull; 2018 Sep; 142():403-408. PubMed ID: 30232045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Juvenile amyotrophic lateral sclerosis.
    Aggarwal A; Shashiraj
    Indian J Pediatr; 2006 Mar; 73(3):225-6. PubMed ID: 16567917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.